SERO Serologicals (MM)

Serologicals Corporation (NASDAQ: SERO) announced today that Michael Monko has joined the Company as Vice President, Sales for the Research Products Segment, consisting of Chemicon International, Inc. and the Upstate Group, Inc. Mr. Monko will report directly to Jeffrey D. Linton, President and will be a member of Research Segment Executive Operating Committee. In his new role, Mr. Monko will direct all sales activities worldwide for the Company's research products and drug discovery markets bringing his many years of expertise in these sectors to our customers and sales team. "We are delighted that Mike has joined the Company at this important time as we accelerate our growth and expand our market leadership positions," said Mr. Linton. "Mike has significant experience in our industry and possesses exceptional leadership skills. His extensive knowledge and background will be beneficial in further expanding our customer development activities. In addition, we are looking forward to him leading our sales teams as they continue to create expanded growth opportunities and through providing focus on the professional development of our research products sales organization." Prior to joining the Company, Mr. Monko worked nearly 20 years for Invitrogen Corporation (NASDAQ: IVGN) in several sales leadership positions. Most recently, he was the Senior Director, Sales Force Effectiveness. Prior to that, he was the Senior Director of Sales, directing the academic and industrial sales organization responsible for developing and implementing strategic sales plans resulting in substantial sales growth for that organization. Mr. Monko received an MBA degree from Babson College in Wellesley, MA and a Bachelor of Science degree in Biochemistry from the University of New Hampshire. Mr. Monko will be based in Serologicals' Temecula, California office. Serologicals Corporation (NASDAQ: SERO), headquartered in Atlanta, GA, is a global leader in developing and commercializing consumable biological products, enabling technologies and services in support of biological research, drug discovery, and the bioprocessing of life-enhancing products. Our customers include researchers at major life science companies and leading research institutions involved in key disciplines, such as neurology, oncology, hematology, immunology, cardiology, proteomics, infectious diseases, cell signaling and stem cell research. In addition, Serologicals is the world's leading provider of monoclonal antibodies for the blood typing industry. Serologicals employs a total of more than 1,000 people worldwide in three Serologicals' companies: Chemicon International, headquartered in Temecula, CA, Upstate Group, LLC, headquartered in Charlottesville, VA and Celliance Corporation, headquartered in Atlanta, GA. For more information, please visit our website: www.serologicals.com. Serologicals is a registered trademark of Serologicals Investment Company.